ABT-510
- Generic Name
- ABT-510
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C46H83N13O11
- CAS Number
- 251579-55-2
- Unique Ingredient Identifier
- CRR8E37XOB
- Background
ABT-510 is a peptide mimetic of thrombospondin-1 (TSP-1), blocks angiogenesis in vitro and in vivo, and slows tumor growth. It is developed by Abbott Laboratories for the treatment of Solid Tumors, Lymphoma and Melanoma.
- Indication
Investigated for use/treatment in lymphoma (unspecified), melanoma, and solid tumors.
- Associated Conditions
- -
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath